BBSRC Portfolio Analyser
Award details
TCS-TARGETS: Bacterial two-component systems as targets for the development of novel antibacterials and anti-infectives
Reference
BBS/E/F/04311142
Principal Investigator / Supervisor
Dr Jerry Wells
Co-Investigators /
Co-Supervisors
Institution
Quadram Institute Bioscience
Department
Quadram Institute Bioscience Department
Funding type
Research
Value (£)
102,291
Status
Completed
Type
Institute Project
Start date
01/11/2000
End date
31/10/2003
Duration
36 months
Abstract
Microbial drug resistance imposes an increasing threat to human and animal health and the development of new drugs to control bacterial infections is therefore urgently needed. The overall objective of this project is to exploit a new class of bacterial targets called two-component systems (TCS) for the development of novel antibacterials and drugs that specifically target the mechanisms by which bacteria establish infection in the host. This objective will be achieved by targetting pan-European critical mass, expertise and support to understanding of the structure, function and biological diversity of these targets. By the end of the project we will expect to have selected appropriate targets and have developed selected assays for inhibitors of those targets that can be used for high throughput screening in the pharmaceutical industry
Summary
unavailable
Committee
Closed Committee - Engineering & Biological Systems (EBS)
Research Topics
X – not assigned to a current Research Topic
Research Priority
X – Research Priority information not available
Research Initiative
X - not in an Initiative
Funding Scheme
X – not Funded via a specific Funding Scheme
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search